Translational Cancer Research

期刊名

Translational Cancer Research

TRANSL CANCER RES

ISSN / eISSN

2218-676X / 2219-6803

目标和范围

Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.

研究方向

肿瘤学

CiteScore

1.20 查看趋势图

CiteScore 学科排名

类别	分区	排名
Medicine - Radiology, Nuclear Medicine and Imaging	Q3	#232/312
Medicine - Oncology	Q4	#290/366
Medicine - Cancer Research	Q4	#187/214

Web of Science 核心合集

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

类别 (Journal Citation Reports 2023)	分区
ONCOLOGY - SCIE	Q4

H-index

22

出版国家或地区

PEOPLES R CHINA

出版商

AME Publishing Company

年文章数

391

Open Access

NO

通讯方式

FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, PEOPLES R CHINA, HONG KONG, 00000